594 related articles for article (PubMed ID: 25045879)
1. Type I and type II Fc receptors regulate innate and adaptive immunity.
Pincetic A; Bournazos S; DiLillo DJ; Maamary J; Wang TT; Dahan R; Fiebiger BM; Ravetch JV
Nat Immunol; 2014 Aug; 15(8):707-16. PubMed ID: 25045879
[TBL] [Abstract][Full Text] [Related]
2. IgG Fc Glycosylation in Human Immunity.
Wang TT
Curr Top Microbiol Immunol; 2019; 423():63-75. PubMed ID: 30805712
[TBL] [Abstract][Full Text] [Related]
3. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
Anthony RM; Ravetch JV
J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
[TBL] [Abstract][Full Text] [Related]
4. IgG cooperativity - Is there allostery? Implications for antibody functions and therapeutic antibody development.
Yang D; Kroe-Barrett R; Singh S; Roberts CJ; Laue TM
MAbs; 2017; 9(8):1231-1252. PubMed ID: 28812955
[TBL] [Abstract][Full Text] [Related]
5. Fcγ receptor pathways during active and passive immunization.
Bournazos S; Ravetch JV
Immunol Rev; 2015 Nov; 268(1):88-103. PubMed ID: 26497515
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.
Mizushima T; Yagi H; Takemoto E; Shibata-Koyama M; Isoda Y; Iida S; Masuda K; Satoh M; Kato K
Genes Cells; 2011 Nov; 16(11):1071-80. PubMed ID: 22023369
[TBL] [Abstract][Full Text] [Related]
7. Functional diversification of IgGs through Fc glycosylation.
Wang TT; Ravetch JV
J Clin Invest; 2019 Sep; 129(9):3492-3498. PubMed ID: 31478910
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
Caaveiro JM; Kiyoshi M; Tsumoto K
Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
[TBL] [Abstract][Full Text] [Related]
9. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
Lu J; Sun PD
Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
[TBL] [Abstract][Full Text] [Related]
10. Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.
Radaev S; Sun PD
J Biol Chem; 2001 May; 276(19):16478-83. PubMed ID: 11297533
[TBL] [Abstract][Full Text] [Related]
11. Recognition of immunoglobulins by Fcgamma receptors.
Radaev S; Sun P
Mol Immunol; 2002 May; 38(14):1073-83. PubMed ID: 11955599
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
Kaneko Y; Nimmerjahn F; Ravetch JV
Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
[TBL] [Abstract][Full Text] [Related]
13. The structure of a human type III Fcgamma receptor in complex with Fc.
Radaev S; Motyka S; Fridman WH; Sautes-Fridman C; Sun PD
J Biol Chem; 2001 May; 276(19):16469-77. PubMed ID: 11297532
[TBL] [Abstract][Full Text] [Related]
14. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
Falconer DJ; Subedi GP; Marcella AM; Barb AW
ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
[TBL] [Abstract][Full Text] [Related]
16. Diversification of IgG effector functions.
Bournazos S; Ravetch JV
Int Immunol; 2017 Jul; 29(7):303-310. PubMed ID: 28472280
[TBL] [Abstract][Full Text] [Related]
17. General mechanism for modulating immunoglobulin effector function.
Sondermann P; Pincetic A; Maamary J; Lammens K; Ravetch JV
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9868-72. PubMed ID: 23697368
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
Sondermann P; Kaiser J; Jacob U
J Mol Biol; 2001 Jun; 309(3):737-49. PubMed ID: 11397093
[TBL] [Abstract][Full Text] [Related]
19. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-Glycan Composition on Structure and Dynamics of IgG1 Fc and Their Implications for Antibody Engineering.
Lee HS; Im W
Sci Rep; 2017 Oct; 7(1):12659. PubMed ID: 28978918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
